Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2018, Article ID 6056948, 8 pages
https://doi.org/10.1155/2018/6056948
Research Article

Protective Effects of Silymarin and Silibinin against DNA Damage in Human Blood Cells

1Laboratório de Radiobiologia e Mutagênese, Instituto de Ciências Biológicas, Universidade Federal de Goiás, Campus II, Goiânia, GO, Brazil
2Laboratório de Mutagênese (LABMUT), Instituto de Ciências Biológicas, Universidade Federal de Goiás, Campus II, Goiânia, GO, Brazil
3Laboratório de Biotecnologia, Câmpus Henrique Santillo, Universidade Estadual de Goiás, Anápolis, GO, Brazil
4Núcleo de Pesquisas Replicon, Escola de Ciências Agrárias e Biológicas, Pontifícia Universidade Católica de Goiás, Goiânia, GO, Brazil

Correspondence should be addressed to Lee Chen-Chen; rb.moc.oohay@ogeelnehc

Received 11 May 2018; Revised 25 July 2018; Accepted 2 September 2018; Published 2 October 2018

Guest Editor: Claudio Tabolacci

Copyright © 2018 Flávio Fernandes Veloso Borges et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. M. Robinson and X. Zhang, The World Medicines Situation 2011 Traditional Medicines: Global Situation, Issues and Challenges, World Heal Organ, 2011.
  2. S. F. AbouZid, S.-N. Chen, and G. F. Pauli, “Silymarin content in Silybum marianum populations growing in Egypt,” Industrial Crops and Products, vol. 83, pp. 729–737, 2016. View at Publisher · View at Google Scholar · View at Scopus
  3. M. Kaur and R. Agarwal, “Silymarin and epithelial cancer chemoprevention: How close we are to bedside?” Toxicology and Applied Pharmacology, vol. 224, no. 3, pp. 350–359, 2007. View at Publisher · View at Google Scholar · View at Scopus
  4. F. Fraschini, G. Demartini, and D. Esposti, “Pharmacology of silymarin,” Clinical Drug Investigation, vol. 22, no. 1, pp. 51–65, 2002. View at Publisher · View at Google Scholar · View at Scopus
  5. E. Köksal, I. Gülçin, S. Beyza, Ö. Sarikaya, and E. Bursal, “In vitro antioxidant activity of silymarin,” Journal of Enzyme Inhibition and Medicinal Chemistry, vol. 24, no. 2, pp. 395–405, 2009. View at Publisher · View at Google Scholar · View at Scopus
  6. R. Agarwal, C. Agarwal, H. Ichikawa, R. P. Singh, and B. B. Aggarwal, “Anticancer potential of silymarin: from bench to bed side,” Anticancer Reseach, vol. 26, no. 6, pp. 4457–4498, 2006. View at Google Scholar · View at Scopus
  7. L. Radko and W. Cybulski, “Application of silymarin in human and animal medicine,” J Pre-Clinical Clin Res, vol. 1, pp. 22–26, 2007. View at Google Scholar
  8. Y. Surh, “Cancer chemoprevention with dietary phytochemicals,” Nature Reviews Cancer, vol. 3, no. 10, pp. 768–780, 2003. View at Publisher · View at Google Scholar · View at Scopus
  9. J. C. Mathers, J. M. Coxhead, and J. Tyson, “Nutrition and DNA repair - Potential molecular mechanisms of action,” Current Cancer Drug Targets, vol. 7, no. 5, pp. 425–431, 2007. View at Publisher · View at Google Scholar · View at Scopus
  10. S. Guarnieri, S. Loft, P. Riso et al., “DNA repair phenotype and dietary antioxidant supplementation,” British Journal of Nutrition, vol. 99, no. 5, pp. 1018–1024, 2008. View at Google Scholar · View at Scopus
  11. R. Kotecha, A. Takami, and J. L. Espinoza, “Dietary phytochemicals and cancer chemoprevention: a review of the clinical evidence,” Oncotarget , vol. 7, no. 32, pp. 52517–52529, 2016. View at Publisher · View at Google Scholar · View at Scopus
  12. T. J. Yates, L. E. Lopez, S. D. Lokeshwar et al., “Dietary Supplement 4-Methylumbelliferone: An Effective Chemopreventive and Therapeutic Agent for Prostate Cancer,” Journal of the National Cancer Institute, vol. 107, no. 7, Article ID djv085, 2015. View at Publisher · View at Google Scholar · View at Scopus
  13. J. W. Fahey and T. W. Kensler, “Role of dietary supplements/nutraceuticals in chemoprevention through induction of cytoprotective enzymes,” Chemical Research in Toxicology, vol. 20, no. 4, pp. 572–576, 2007. View at Publisher · View at Google Scholar · View at Scopus
  14. D. Fu, J. A. Calvo, and L. D. Samson, “Balancing repair and tolerance of DNA damage caused by alkylating agents,” Nature Reviews Cancer, vol. 12, no. 2, pp. 104–120, 2012. View at Publisher · View at Google Scholar · View at Scopus
  15. A. Kitanovic, T. Walther, M. O. Loret et al., “Metabolic response to MMS-mediated DNA damage in Saccharomyces cerevisiae is dependent on the glucose concentration in the medium,” FEMS Yeast Research, vol. 9, no. 4, pp. 535–551, 2009. View at Publisher · View at Google Scholar · View at Scopus
  16. M. Bijak, E. Synowiec, P. Sitarek, T. Sliwiński, and J. Saluk-Bijak, “Evaluation of the cytotoxicity and genotoxicity of flavonolignans in different cellular models,” Nutrients, vol. 9, no. 12, 2017. View at Google Scholar · View at Scopus
  17. Y. Jiang, S. Shan, L. Chi et al., “Methyl methanesulfonate induces necroptosis in human lung adenoma A549 cells through the PIG-3-reactive oxygen species pathway,” Tumor Biology, vol. 37, no. 3, pp. 3785–3795, 2016. View at Publisher · View at Google Scholar · View at Scopus
  18. N. P. Singh, M. T. McCoy, R. R. Tice, and E. L. Schneider, “A simple technique for quantitation of low levels of DNA damage in individual cells,” Experimental Cell Research, vol. 175, no. 1, pp. 184–191, 1988. View at Publisher · View at Google Scholar · View at Scopus
  19. A. Collins, G. Koppen, V. Valdiglesias et al., “The comet assay as a tool for human biomonitoring studies: The ComNet Project,” Mutation Research - Reviews in Mutation Research, vol. 759, no. 1, pp. 27–39, 2014. View at Publisher · View at Google Scholar · View at Scopus
  20. M. D. Waters, A. L. Brady, H. F. Stack, and H. E. Brockman, “Antimutagenicity profiles for some model compounds,” Mutation Research/Reviews in Genetic Toxicology, vol. 238, no. 1, pp. 57–85, 1990. View at Publisher · View at Google Scholar · View at Scopus
  21. A. Svobodová, A. Zdařilová, J. Mališková, H. Mikulková, D. Walterová, and J. Vostalová, “Attenuation of UVA-induced damage to human keratinocytes by silymarin,” Journal of Dermatological Science, vol. 46, no. 1, pp. 21–30, 2007. View at Publisher · View at Google Scholar · View at Scopus
  22. L. R. Ferguson, “Role of plant polyphenols in genomic stability,” Mutation Research, vol. 475, no. 1-2, pp. 89–111, 2001. View at Publisher · View at Google Scholar · View at Scopus
  23. Š. Chlopčíková, J. Psotová, P. Miketová, and V. Šimánek, “Chemoprotective Effect of Plant Phenolics against Anthracycline-induced Toxicity on Rat Cardiomyocytes. Part I. Silymarin and its Flavonolignans,” Phytotherapy Research, vol. 18, no. 2, pp. 107–110, 2004. View at Publisher · View at Google Scholar · View at Scopus
  24. A. Pietrangelo, F. Borella, G. Casalgrandi et al., “Antioxidant activity of silybin in vivo during long-term iron overload in rats,” Gastroenterology, vol. 109, no. 6, pp. 1941–1949, 1995. View at Publisher · View at Google Scholar · View at Scopus
  25. P. Tiwari, A. Kumar, M. Ali, and K. Mishra, “Radioprotection of plasmid and cellular DNA and Swiss mice by silibinin,” Mutation Research - Genetic Toxicology and Environmental Mutagenesis, vol. 695, no. 1-2, pp. 55–60, 2010. View at Publisher · View at Google Scholar
  26. J. Zhao, M. Lahiri-Chatterjee, Y. Sharma, and R. Agarwal, “Inhibitory effect of a flavonoid antioxidant silymarin on benzoyl peroxide-induced tumor promotion, oxidative stress and inflammatory responses in SENCAR mouse skin,” Carcinogenesis, vol. 21, no. 4, pp. 811–816, 2000. View at Publisher · View at Google Scholar · View at Scopus
  27. D. T. Beranek, “Distribution of methyl and ethyl adducts following alkylation with monofunctional alkylating agents,” Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, vol. 231, no. 1, pp. 11–30, 1990. View at Publisher · View at Google Scholar · View at Scopus
  28. K. Habas, M. Najafzadeh, A. Baumgartner, M. H. Brinkworth, and D. Anderson, “An evaluation of DNA damage in human lymphocytes and sperm exposed to methyl methanesulfonate involving the regulation pathways associated with apoptosis,” Chemosphere, vol. 185, pp. 709–716, 2017. View at Publisher · View at Google Scholar · View at Scopus
  29. F. F. V. Borges, C. R. Silva, J. H. Véras, C. G. Cardoso, A. D. da Cruz, and L. C. Chen, “Antimutagenic, Antigenotoxic, and Anticytotoxic Activities of Silybum Marianum [L.] Gaertn Assessed by the Salmonella Mutagenicity Assay (Ames Test) and the Micronucleus Test in Mice Bone Marrow,” Nutrition and Cancer, vol. 68, no. 5, pp. 848–855, 2016. View at Publisher · View at Google Scholar · View at Scopus
  30. V. A. Toğay, T. S. Sevimli, M. Sevimli, D. A. Çelik, and N. Özçelik, “DNA damage in rats with streptozotocin-induced diabetes; protective effect of silibinin,” Mutation Research - Genetic Toxicology and Environmental Mutagenesis, vol. 825, pp. 15–18, 2018. View at Publisher · View at Google Scholar · View at Scopus
  31. T. Walle, “Absorption and metabolism of flavonoids,” Free Radical Biology & Medicine, vol. 36, no. 7, pp. 829–837, 2004. View at Publisher · View at Google Scholar · View at Scopus
  32. W. H. Shen, A. S. Balajee, J. Wang et al., “Essential Role for Nuclear PTEN in maintaining chromosomal integrity,” Cell, vol. 128, no. 1, pp. 157–170, 2007. View at Publisher · View at Google Scholar · View at Scopus
  33. Y. Yin and W. H. Shen, “PTEN: a new guardian of the genome,” Oncogene, vol. 27, no. 41, pp. 5443–5453, 2008. View at Publisher · View at Google Scholar · View at Scopus
  34. R. J. Youle and A. Strasser, “The BCL-2 protein family: opposing activities that mediate cell death,” Nature Reviews Molecular Cell Biology, vol. 9, no. 1, pp. 47–59, 2008. View at Publisher · View at Google Scholar · View at Scopus
  35. Z.-L. Bai, V. Tay, S.-Z. Guo, J. Ren, and M.-G. Shu, “Silibinin Induced Human Glioblastoma Cell Apoptosis Concomitant with Autophagy through Simultaneous Inhibition of mTOR and YAP,” BioMed Research International, vol. 2018, Article ID 6165192, 10 pages, 2018. View at Publisher · View at Google Scholar
  36. H. Cui, T. Li, H. Guo et al., “Silymarin-mediated regulation of the cell cycle and DNA damage response exerts antitumor activity in human hepatocellular carcinoma,” Oncology Letters, vol. 15, no. 1, pp. 885–892, 2018. View at Publisher · View at Google Scholar
  37. R. Haddadi, A. M. Nayebi, and S. Eyvari Brooshghalan, “Silymarin prevents apoptosis through inhibiting the Bax/caspase-3 expression and suppresses toll like receptor-4 pathway in the SNc of 6-OHDA intoxicated rats,” Biomedicine & Pharmacotherapy, vol. 104, pp. 127–136, 2018. View at Publisher · View at Google Scholar
  38. S. Panjarian, R. E. Iacob, S. Chen, J. R. Engen, and T. E. Smithgall, “Structure and dynamic regulation of abl kinases,” The Journal of Biological Chemistry, vol. 288, no. 8, pp. 5443–5450, 2013. View at Publisher · View at Google Scholar · View at Scopus
  39. F. F. V. Borges, Atividades antimutagênica, antigenotóxica e anticitotóxica de Silybum marianum (L.) Gaertn e sua influência na expressão de genes de resposta a danos no DNA [Ph.D. thesis], Universidade Federal de Goiás, 2015.